Clinical Trial Update: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of TORL-2-307-MAB in participants with advanced cancer, including gastric cancer, pancreatic cancer, and gastroesophageal junction …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• TORL-2-307-MAB

Snippet

Sponsor: TORL Biotherapeutics, LLC | Conditions: Advanced Solid Tumor, Gastric Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING